FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13102511000001106: Acamprosate 333mg gastro-resistant tablets 60 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
45991301000001119 Acamprosate 333mg gastro-resistant tablets 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
45991401000001110 Acamprosate 333mg gastro-resistant tablets 60 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Acamprosate 333mg gastro-resistant tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets 60 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets 60 tablet Is pack of Product containing precisely acamprosate calcium 333 milligram/1 each gastro-resistant oral tablet false Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets 60 tablet Has active ingredient Acamprosate calcium false Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets 60 tablet Has manufactured dose form Gastro-resistant oral tablet false Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets 60 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets 60 tablet Has VMP Product containing precisely acamprosate calcium 333 milligram/1 each gastro-resistant oral tablet true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets 60 tablet Has specific active ingredient Acamprosate calcium true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets 60 tablet Has dispensed dose form Gastro-resistant oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Campral EC 333mg tablets (Dowelhurst Ltd) 60 tablet Is a True Acamprosate 333mg gastro-resistant tablets 60 tablet Inferred relationship Existential restriction modifier
Campral EC 333mg tablets (Doncaster Pharmaceuticals Ltd) 60 tablet Is a True Acamprosate 333mg gastro-resistant tablets 60 tablet Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 60 tablet Is a True Acamprosate 333mg gastro-resistant tablets 60 tablet Inferred relationship Existential restriction modifier
Campral EC 333mg tablets (Sigma Pharmaceuticals Plc) 60 tablet Is a True Acamprosate 333mg gastro-resistant tablets 60 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start